Resources

http://www.hsc.unt.edu/education/pace/online.cfm

http://www.ceconcepts.net/

http://www.impactedu.net/activities.htm

http://www.axdevgroup.com/index.php?language=en

http://www.mededarchitects.com/

http://thecmelounge.com/2/

http://www.mycme.com/

http://www.mdlinx.com/

Presentation Slides for Jeffrey Crawford, MD: Measuring the Clinical Benefit of Maintenance Chemotherapy.

Presentation Slides for Mark A. Socinski, MD: Relevance of Tumor Histology in the Treatment of Advanced NSCLC.

Presentation Slides for Everett E. Vokes, MD: The Role of Biomarker Analysis in Personalized Treatment Planning.

1. National Comprehensive Cancer Network guidelines: http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf
2. American Society for Clinical Oncology guidelines: Azzoli CG, Baker S, Jr., Temin S, et al. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol. 2009;27(36):6251-6266.
3. European Society Medical Oncology guidelines: http://www.esmo.org/research/esmo-clinical-practice-guidelines.html#c3341
4. National Lung Cancer Partnership http://www.nationallungcancerpartnership.org/index.cfm